CDKN2A/p14ARFAntibody Blocking Peptide
This product is CDKN2A/p14ARFAntibody Blocking Peptide. It targets Tumor suppressor ARF. Purification is performed using HPLC.
Product Specifications
Product Name Alternative
CDKN2A; p16INK4a; INK4; P16INK4; ARF; CCM2; CDK4 Inhibitor; CDK4 inhibitor p16 INK4; CDK4I; CDKN2; CDKN2A; Cell cycle negative regulator beta; CMM2; Cyclin dependent kinase 4 inhibitor A; Cyclin dependent kinase inhibitor 2A (melanoma p16 inhibits CDK4) ; Cyclin Dependent Kinase Inhibitor 2A; Cyclin dependent kinase inhibitor 2A isoform 4; Cyclin dependent kinase inhibitor 2A isoforms 1/2/3; Cyclin dependent kinase inhibitor p16; INK4A; MLM; MTS1; Multiple tumor suppressor 1; Multiple Tumor Supressor 1; p14; p14 (ARF) ; p14ARF; p16; p16 INK4; p16INK4; p16INK4a; p19; p19 (ARF) ; p19Arf; TP16.
Field of Research
Cancer Research, Cell Cycle, Epigenetics and Nuclear Signaling, Tumor Suppressors, p53 Signaling Pathway
Storage Conditions
Shipped at 4°C. Stored at -20°C for one year. Avoid repeated freeze/thaw cycles.
Notes
For research use only.
More Discoveries
Explore Other Products
Browse additional items from our catalog
